MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2023 International Congress

    Slow progressive neurocognitive impairment with Parkinsonism: A rare, adult-onset Neuronal Intranuclear Inclusion disease (NIID) case report

    AS. Mawardi, AA. Ab Ghapar, NH. Rahim, J. Joseph (Kuala Lumpur, Malaysia)

    Objective: We described a case of a 62-years old lady with underlying diabetes and hypertension, presented with  right upper intermittent resting tremor and stiffness for…
  • 2023 International Congress

    Modulation of autophagy and neuroinflammation by Niclosamide in MPTP Induced- Parkinson’s disease model

    SHI. Kartik (Lucknow, India)

    Objective: The current investigation aimed to investigate the neuroprotective effect of niclosamide (NI) on autophagy and neuroinflammatory pathways in Parkinson’s disease (PD). Background: Autophagy dysregulation…
  • 2023 International Congress

    Subacute parkinsonism associated with Zic4 antibodies: a case report

    V. Mendes Ferreira, M. Magriço, D. Krupka, B. Meira (Lisboa, Portugal)

    Objective: Describe a case of subacute parkinsonism associated with isolated Zic4 antibodies. Background: Movement disorders are a common feature in autoimmune encephalitis and its presentation…
  • 2023 International Congress

    Effect of ventricular morphometrics on the treatment of Parkinson’s disease

    JJ. Lee, YB. Yong, JS. Baik (Goyang-si, Republic of Korea)

    Objective: To explore the impact of the cerebral ventricular dimension on treatment response in Parkinson’s disease (PD). Background: In addition to PD, the second most…
  • 2023 International Congress

    Use and Misuse of the Unified Multiple System Atrophy Rating Scale

    A. Ferreirós, S. Castillo-Torres, M. Merello (Buenos Aires, Argentina)

    Objective: To quantify the use and variation of the motor part of Unified Multiple System Rating Scale (UMSARS II) on prospectively planned studies. Background: Despite…
  • 2023 International Congress

    Understanding Social Isolation before, during and after the Covid-19 pandemic among Patients with Parkinson’s disease

    A. Mehta, S. Ng, N. Chia, X. Choi, D. Heng, S. Neo, Z. Xu, K. Tay, W. Au, E. Tan, L. Tan (Singapore, Singapore)

    Objective: The aim of this study was to understand and measure the effect of social network support in patients with Parkinson’s disease(PwP) before, during and…
  • 2023 International Congress

    Describing the syndrome: a comprehensive analysis of a large cohort of corticobasal syndrome with pathological correlation

    D. Vaughan, M. Theilmann Jensen, D. Lux, L. Wu, Z. Jaunmuktane, T. Revesz, T. Lynch, M. Stamelou, K. Seppi, R. Vandenberghe, T. Warner, K. Bhatia, A. Lees, A. Church, N. Leigh, P. Taba, T. Matsalu, P. Mir, B. Ghosh, M. Picillo, J. Wallin, P. Svenningsson, Y. Compta, J. Rohrer, J. Rowe, H. Morris (London, United Kingdom)

    Objective: To describe the clinical, biomarker, genetic and pathological features of a cohort of patients with corticobasal syndrome (CBS). Background: Corticobasal degeneration (CBD) was first…
  • 2023 International Congress

    6-[18F]fluoro-L-3,4-dihydroxyphenylalanine (F-DOPA) PET striatal binding patterns in patients with Parkinson’s Disease and Parkinson Plus Syndromes.

    A. Buckland, T. Lee, R. Stell, S. Ghosh, J. Rodrigues, W. Yau, S. Vijayan, R. Francis, K. Sek, L. Morandeau, A. Jacques, T. Hagan, J. Watts, E. Campbell, N. Loh (Nedlands, Australia)

    Objective: In this study we investigate striatal binding patterns in patients with Idiopathic Parkinson’s disease (IPD), compared to those with Parkinson Plus syndromes (PPS) versus…
  • 2023 International Congress

    Case report- Cavernoma involving substantia nigra and nigrostriatal pathway as a rare cause of secondary parkinsonism with a 3 year follow up

    S. Sathyanarayana, J. Pasquini, D. Ledingham, D. Mitra, N. Warren, N. Pavese (Newcastle Upon Tyne, United Kingdom)

    Objective: To describe a case report of a rare cause of Parkinsonism Background: Vascular malformations such as cerebral cavernomas are known to predispose to haemorrhagic…
  • 2023 International Congress

    Wilson disease: a single-center study from Tunisia

    R. Zouari, R. Amouri, I. Ben Kraiem, MZ. Saeid, F. Nabli, S. Ben Sassi (Tunis, Tunisia)

    Objective: We aimed to describe different clinical and radiological presentations of WD and insist on the necessity of early diagnosis to ensure therapeutic efficiency. Background:…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Nilotinib for treating MSA: A preclinical proof of concept study
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley